Numair Arshad

Faculty

Numair Arshad is a dedicated student pursuing a Doctor of Pharmacy (PharmD) degree with a keen interest in pharmacology and life sciences. With a robust background in scientific writing, Numair has honed his skills during his tenure as a medical writer at Rhenix LifeSciences. During this time, he authored nearly 50 detailed white papers on various disease subjects, in addition to a comprehensive review paper. His expertise extends to delivering engaging CellTalk presentations, showcasing his proficiency in communicating complex scientific concepts effectively.

Over the past three years, Numair has immersed himself in scientific writing. At Rhenix LifeSciences, he played a pivotal role in producing high-quality scientific content, demonstrating his commitment to advancing knowledge in life sciences.

Numair's passion lies in the intersection of pharmacology and omics, where he sees immense potential for revolutionizing drug development and identifying novel therapeutic targets. He is deeply enthusiastic about leveraging omics technologies and bioinformatics to streamline the drug development process and catalyze advancements in medical research.

With a dedication to scientific writing and a profound interest in the omics field, Numair Arshad is poised to make significant contributions to the intersection of pharmacology, omics, and medical writing.

Google Scholar

Recent Publications

Link to full Article

MicroRNA-21 Silencing in Diabetic Nephropathy: Insights on Therapeutic Strategies; Yogita Dhas, Numair Arshad, Nupur Biswas, Lawrence Jones, and Shashaanka Ashili; Biomedicines 11 (9), 2583 (2023).

Diabetic kidney disease is a grave complication leading to kidney damage and silencing of microRNA-21 is a promising treatment avenue. It requires an understanding of miR-21's involvement in diabetic induced kidney damage. Various methods for miR 21 silencing are under preliminary exploration. Current research offers hope for enhancing the quality of life for individuals affected by diabetic induced kidney disease.

Link to full Article

Huntington’s Disease

Huntington’s disease (HD) is a rare but devastating neurodegenerative disorder. HD is more prevalent in western countries. HD patients suffer from neuropsychiatric, cognitive, and motor symptoms. Uncontrolled and irregular movements called chorea are the characteristic symptom of HD. Neuropsychiatric symptoms occur nearly a decade after motor symptoms are detected. Upon the appearance of early motor symptoms, an evaluation of family history is sufficient for the diagnosis of HD. However, a genetic test is not definitive regarding the presence or absence of HD.

Numair Arshad

Recent Publications

Collaborators